BACKGROUND OF THE INVENTION
[0001] The application of specific electrical energy to the spinal cord for the purpose
of managing pain has been actively practiced since the 1960s. It is known that application
of an electrical field to spinal nervous tissue can effectively mask certain types
of pain transmitted from regions of the body associated with the stimulated nervous
tissue. Such masking is known as paresthesia, a subjective sensation of numbness or
tingling in the afflicted bodily regions. Such electrical stimulation of the spinal
cord, once known as dorsal column stimulation, is now referred to as spinal cord stimulation
or SCS.
[0002] Figs. 1A-1B illustrate conventional placement of an SCS system 10. Conventional SCS
systems typically include an implantable power source or implantable pulse generator
(IPG) 12 and an implantable lead 14. Such IPGs 12 are similar in size and weight to
pacemakers and are typically implanted in the buttocks of a patient P, as shown, or
in the abdominal wall, chest wall, or under the arm. Using fluoroscopy, the lead 14
is implanted into the epidural space E of the spinal column and positioned against
the dura layer D of the spinal cord S, as illustrated in Fig. 1B.
[0003] Fig. 2 illustrates example conventional paddle leads 16 and percutaneous leads 18.
Paddle leads 16 typically have the form of a slab of silicon rubber having one or
more electrodes 20 on its surface. Example dimensions of a paddle lead 16 are illustrated
in Fig. 3. Percutaneous leads 18 typically have the form of a tube or rod having one
or more electrodes 20 extending therearound. Example dimensions of a percutaneous
lead 18 are illustrated in Fig. 4.
[0004] Paddle leads 16 and percutaneous leads 18 are positioned within the epidural space
E of the spinal column by different methods due to their size and shape. Percutaneously
leads 18 are positioned with the use of an epidural needle. Referring to Fig. 5, an
epidural needle 22 is inserted through the skin (not shown) and advanced between adjacent
vertebrae V1, V2 so that it penetrates the epidural space. Thus, a conduit is formed
from outside of the body to the epidural space. The lead 18 is then advanced through
the needle 22 and into the epidural space. The lead 18 is typically advanced in an
antegrade fashion up the midline of the spinal column until it reaches the area of
the spinal cord that, when electrically stimulated, produces a tingling sensation
(paresthesia) that covers the patient's painful area. To locate this area, the lead
is moved and/or turned on and off while the patient provides feedback about stimulation
coverage. Often, inadequate stimulation is obtained and the lead may be repositioned
multiple times before adequate coverage is received. Because the patient participates
in this operation and directs the operator to the correct area of the spinal cord,
the procedure is performed under monitored anesthesia care.
[0005] Conventional paddle leads 16 are too large to fit through an epidural needle. Therefore,
implantation of paddle leads 16 typically involves a mini laminotomy. A laminotomy
is a neurosurgical procedure that removes part of a lamina of the vertebral arch.
An incision is typically made slightly below the spinal cord segment to be stimulated.
The laminotomy creates an opening 24 in the bone large enough to pass one or more
paddle leads 16 through. Fig. 6 illustrates a mini laminotomy with a paddle lead 16
inserted therethrough so that the stimulating portion of the lead 16 resides against
the dura layer D of the spinal cord S. The target area for stimulation usually has
been located before this procedure during a spinal cord stimulation trial with percutaneous
leads 18.
[0006] As with any surgery, surgical placement of stimulation leads is a serious procedure
and should be treated as such. A variety of complications may result, including complications
with the anesthesia medication, deep vein thrombosis (DVT), nerve damage, and infection,
to name a few. Thus, less invasive procedures are desired. Such procedures should
be effective in treating pain while minimizing complications, cost and debilitation.
At least some of these objectives will be met by the present invention.
[0007] US 2003/0144657 discloses a catheter delivery system having inner and outer catheters, both of which
have curved distal ends. The catheter assembly can include at least one electrode
at the distal end of either the inner or outer catheter. A pacing lead can also be
inserted through the inner or outer catheter.
[0008] US 2005/0251237 discloses a system having a lead carrying an electrode and an insertion tube.
[0009] US 2008/0009927 discloses a device comprising an electrical stimulation lead and an introducer needle,
which can have a bent distal tip. The document also discloses a device having a sheath
that is placed within an introducer needle and a stimulation lead that is placed within
the sheath.
[0010] US 2008/0103579 discloses a system comprising a medical lead and an outer sheath for enclosing the
lead. The lead comprises an electrode and an adhesive element.
[0011] US 2008/0183257 discloses a system having a lead carrying an electrode and a retention feature to
assist with anchoring the lead.
[0012] US 2008/0140169 discloses a system having a lead carrying an electrode and an implantable pulse generator.
BRIEF SUMMARY OF THE INVENTION
[0014] According to the present invention there is provided a system for accessing a nerve
root according to claim 1.
[0015] The present invention provides a system for accessing and treating anatomies associated
with a variety of conditions while minimizing possible complications and side effects.
This is achieved by directly neuromodulating a target anatomy associated with the
condition while minimizing or excluding undesired neuromodulation of other anatomies.
Typically, this involves stimulating portions of neural tissue of the central nervous
system, wherein the central nervous system includes the spinal cord and the pairs
of nerves along the spinal cord which are known as spinal nerves. In particular, some
embodiments of the present invention are used to selectively stimulate portions of
the spinal nerves, particularly one or more dorsal root ganglions (DRGs), to treat
chronic pain while causing minimal deleterious side effects such as undesired motor
responses. Such stimulation is achieved with the use of a lead having at least one
electrode thereon. The lead is advanced through the patient anatomy so that the at
least one electrode is positioned on, near or about the target anatomy.
[0016] The present system includes a lead comprising a shaft having at least one electrode
disposed thereon, and a sheath having a curved distal end, wherein the sheath is configured
to extend over the shaft of the lead causing the lead to bend. In an embodiment, the
sheath has an outer diameter which allows advancement through an introducing needle
into an epidural space of a spinal column and a stiffness which allows advancement
along the epidural space to a position wherein the curved distal end of the sheath
directs the lead toward the spinal nerve, and wherein withdrawal of the sheath positions
the lead near the spinal nerve.
[0017] In some embodiments, the introducing needle has an inner diameter of less than or
equal to approximately 1.7 mm (0.067 inches). Typically, a 14 gauge needle has an
inner diameter of 0.067 inches. In other embodiments, the sheath has a minimum stiffness
of approximately 4.48 kPa (0.65 lbs·in2). The sheath may be comprised of a variety
of materials, such as polyimide or polyetheretherketone. In some embodiments, the
lead has a shaped distal tip, wherein the sheath is configured to extend over the
shaft of the lead until a portion of the distal end abuts the shaped distal tip of
the lead resisting further advancement of the sheath. Optionally, the distal tip of
the lead provides an atraumatic cover for the distal end of the sheath.
[0018] The lead includes a stylet lumen extending at least partially therethrough, wherein
the system includes a stylet configured to be positioned within the stylet lumen of
the lead so that advancement of the stylet and withdrawal of the sheath positions
the lead near the spinal nerve. The style has a curved distal end, wherein the positioning
the curved distal end of the sheath over the lead bends the lead along a first curvature
toward the spinal nerve and wherein advancement of the lead and stylet therein beyond
the sheath bends the lead along a second curvature so that the lead extends from the
spinal column along a nerve root angulation. In some instances, the nerve root angulation
is equal to or less than 90 degrees. And in some instances, the nerve root angulation
is equal to or less than 45 degrees. In some embodiments, the distal end of the stylet
is curved having a primary curve and a secondary curve.
[0019] In some embodiments, the system further comprises an additional sheath having a distal
end, wherein the additional sheath is configured to pass within the sheath so that
its distal end extends beyond the curved distal end of the sheath. The distal end
of the additional sheath may be curved so that positioning the curved distal end of
the sheath over the lead bends the lead along a first curvature toward the spinal
nerve and wherein advancement of the curved distal end of the additional sheath beyond
the curved distal end of the sheath bends the lead along a second curvature toward
a nerve root angulation. Or the distal end of the additional sheath may be substantially
straight so that positioning the curved distal end of the sheath over the lead bends
the lead along a first curvature toward the spinal nerve and wherein advancement of
the curved distal end of the additional sheath beyond the curved distal end of the
sheath directs the lead in a substantially straight direction toward the spinal nerve.
[0020] In some embodiments, the distal end of the sheath is curved having an angle in the
range of approximately 80 to 165 degrees. In other embodiments, the distal end of
the stylet is curved having a primary curve and a secondary curve. Optionally, the
primary curve may have an arch shape of approximately 180 degrees. Optionally, the
secondary curve may be proximal and adjacent to the primary curve. Optionally, the
secondary curve may have a larger radius of curvature than the primary curve. In some
embodiments, the lead has a closed-end distal tip having a shape which resists advancement
of the sheath over the distal tip. Optionally, the shape may comprise a ball shape.
[0021] In some embodiments, the lead is sized to fill an inner diameter of the sheath so
as to resist kinking of the sheath. In other embodiments, the shaped distal tip of
the lead provides an atraumatic cover for the distal end of the sheath.
[0022] In some embodiments, the sheath is comprised of a thermoset material. In some embodiments,
the sheath is comprised of a unidurometer material. Optionally, the sheath may be
at least partially radiopaque, such as loaded with radiopaque material. Or, the sheath
may include at least one radiopaque marker.
[0023] In an embodiment, first and second sheaths together have a stiffness which allows
advancement along the epidural space to a position wherein the distal ends of the
first and second sheaths direct the lead toward the spinal nerve.
[0024] In some embodiments, advancement of the lead and stylet therein beyond the second
sheath bends the lead along a second curvature so that the lead extends from the spinal
column along a nerve root angulation. Optionally, the system further comprises a control
hub connectable with a proximal end of the first sheath and a proximal end of the
second sheath, wherein manipulation of the control hub moves the first or second sheath
in relation to each other. In some embodiments, the control hub includes a limiter,
wherein the limiter limits the movement of the first or second sheath in relation
to each other. In some embodiments, manipulation of the control hub is achievable
with the use of one hand.
[0025] In an embodiment, the stimulation lead comprises a shaft comprising a tube having
a distal end and a proximal end, a stylet tube disposed within the shaft, at least
one electrode disposed near the distal end of the shaft, and at least one conductor
cable extending from the at least one electrode toward the proximal end of the shaft.
The stylet tube is fixedly coupled to the shaft at a first location near the distal
end and at a second location proximal to the first location allowing for movement
of the stylet tube within the shaft therebetween.
[0026] In some embodiments, the at least one conductor cable is disposed between the stylet
tube and shaft, wherein the at least one conductor cable is fixedly coupled to the
shaft near the proximal end and another location allowing for movement within the
shaft therebetween. In some embodiments, the lead further comprises a tensile element
fixedly coupled to the shaft in at least one location along the shaft. Optionally,
the tensile element may have freedom of movement within the shaft outside of the at
least one location. In some embodiments, the tensile element has multiple diameters.
For example, the tensile element may have a larger diameter near its proximal end
and neck down toward its distal end. In some embodiments, the stylet tube has a lubricious
inner surface. Optionally, the stylet tube may be comprised of polyimide.
[0027] In some embodiments, at least a portion of the distal end of the shaft is configured
to extend at least 180 degrees along the perimeter of a half circle, wherein the half
circle has a radius of 6.35 mm (0.25 inches).
[0028] Other objects and advantages of the present invention will become apparent from the
detailed description to follow, together with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0029]
Figs. 1A, 1B, 2, 3, 4, 5, 6 illustrate prior art.
Fig. 7 illustrates a lead advanced through a nerve root sleeve angulation so that
at least one of its electrodes is positioned within a clinically effective distance
of a target DRG.
Figs. 8A, 8B, 8C, 8D illustrate an embodiment of a lead and delivery system, including
a sheath, stylet and introducing needle of the present invention.
Fig. 9 illustrates an embodiment of a sheath advanced over a shaft of a lead with
internal stylet forming a first curvature.
Fig. 10 illustrates the lead with internal stylet of Fig. 9 extending beyond the sheath
forming a second curvature.
Fig. 11 illustrates a method of accessing an epidural space with the use of an introducing
needle.
Fig. 12 illustrates a method of attaching a syringe to the needle of Fig. 11.
Fig. 13 illustrates a method of inserting a stylet, lead and sheath of the present
invention through the needle of Fig. 11 into the epidural space.
Fig. 14 illustrates the distal end of the needle passed through the ligamentum flavum
into the epidural space and the assembled sheath/lead/stylet of Fig. 13 emerging therefrom.
Fig. 15 illustrates advancing the assembled sheath/lead/stylet of Fig. 13 within the
epidural space toward a target DRG.
Fig. 16 illustrates the precurvature of the sheath directing the lead laterally outwardly.
Fig. 17 illustrates the lead extending beyond the distal end of the sheath of Fig.
16.
Fig. 18 illustrates a method of using the needle of Fig. 11 to position an additional
lead within the epidural space.
Fig. 19 illustrates an additional assembled sheath/lead/stylet advanced within the
epidural space toward another or second target DRG.
Fig. 20 illustrates the precurvature of the sheath of Fig. 19 directing the lead laterally
outwardly.
Fig. 21 illustrates the lead advanced beyond the distal end of the sheath of Fig.
20.
Fig. 22 illustrates a plurality of leads positioned within the epidural space, each
lead stimulating a different DRG.
Fig. 23A illustrates an embodiment of a sheath of the present system.
Fig. 23B illustrates an embodiment of a hub having a locking cap and injection port.
Figs. 24A, 24B, 24C, 24D, 24E illustrate an embodiment of a lead of the present system.
Fig. 24F illustrates an embodiment lead of the present system comprising a multi-lumen
tubing.
Figs. 25, 26A-26B illustrate embodiments of a stylet of the present system.
Fig. 27 illustrates an embodiment of a system of the present invention having multiple
sheaths.
Fig. 28 illustrates the system of Fig. 27 positioned within the epidural space.
Figs. 29A, 29B, 29C illustrate a perspective view, a side view and a front view, respectively,
of an embodiment of a control hub.
Fig. 30 illustrates a conventional stimulation system used to stimulate tissues or
organs within the body.
Fig. 31 illustrates an embodiment of a strain relief support of the present system.
Fig. 32 illustrates a cross-section of the strain relief support, including the support
member and the hub.
Figs. 33-36 illustrate insertion of the support member into the proximal end of a
lead and detachment of the hub.
Fig. 37 illustrates the proximal end of the lead inserted into the connection port
of the IPG.
DETAILED DESCRIPTION OF THE INVENTION
[0030] The present invention provides systems for accessing and treating anatomies associated
with a variety of conditions, particularly conditions that are associated with or
influenced by the nervous system. Examples of such conditions include pain, itching,
Parkinson's Disease, Multiple Sclerosis, demylenating movement disorders, spinal cord
injury, asthma, chronic heart failure, obesity and stroke (particularly acute ischemia),
to name a few. Typically, the systems are used to stimulate portions of neural tissue
of the central nervous system, wherein the central nervous system includes the spinal
cord and the pairs of nerves along the spinal cord which are known as spinal nerves.
The spinal nerves include both dorsal and ventral roots which fuse in the intravertebral
foramen to create a mixed nerve which is part of the peripheral nervous system. At
least one dorsal root ganglion (DRG) is disposed along each dorsal root prior to the
point of mixing. Thus, the neural tissue of the central nervous system is considered
to include the dorsal root ganglions and exclude the portion of the nervous system
beyond the dorsal root ganglions, such as the mixed nerves of the peripheral nervous
system.
[0031] In some embodiments, the systems of the present invention are used to stimulate one
or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof.
Accessing these areas is challenging, particularly from an antegrade epidural approach.
Fig. 7 schematically illustrates portions of the anatomy in such areas. As shown,
each DRG is disposed along a dorsal root DR and typically resides at least partially
between the pedicles PD or within a foramen. Each dorsal root DR exits the spinal
cord S at an angle θ. This angle θ is considered the nerve root sleeve angulation
and varies slightly by patient and by location along the spinal column. The average
nerve root angulation in the lumbar spine is significantly less than 90 degrees and
typically less than 45 degrees. Therefore, accessing this anatomy from an antegrade
approach involves making a sharp turn through, along or near the nerve root sleeve
angulation. It may be appreciated that such a turn may follow the nerve root sleeve
angulation precisely or may follow various curves in the vicinity of the nerve root
sleeve angulation.
[0032] Fig. 7 illustrates a lead 100 inserted epidurally and advanced in an antegrade direction
along the spinal cord S. The lead 100, having at least one electrode 102 thereon,
is advanced through the patient anatomy so that at least one of the electrodes 102
is positioned on a target DRG. Such advancement of the lead 100 toward the target
DRG in this manner involves making a sharp turn along the angle θ. A turn of this
severity is achieved with the use of delivery tools and design features of the present
invention specific to such lead placement. In addition, the spatial relationship between
the nerve roots, DRGs and surrounding structures are significantly influenced by degenerative
changes, particularly in the lumbar spine. Thus, patients may have nerve root angulations
which differ from the normal anatomy, such as having even smaller angulations necessitating
even tighter turns. The present invention also accommodates these anatomies.
[0033] The systems of the present invention allow for targeted treatment of the desired
anatomies. Such targeted treatment minimizes deleterious side effects, such as undesired
motor responses or undesired stimulation of unaffected body regions. This is achieved
by directly neuromodulating a target anatomy associated with the condition while minimizing
or excluding undesired neuromodulation of other anatomies. For example, this may include
stimulating the dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions
thereof while minimizing or excluding undesired stimulation of other tissues, such
as surrounding or nearby tissues, portions of the ventral root and portions of the
anatomy associated with body regions which are not targeted for treatment. Such stimulation
is achieved with the use of a lead having at least one electrode thereon. The lead
is advanced through the patient anatomy so that the at least one electrode is positioned
on, near or about the target. In some embodiments, the lead and electrode(s) are sized
and configured so that the electrode(s) are able to minimize or exclude undesired
stimulation of other anatomies. In other embodiments, the stimulation signal or other
aspects are configured so as to minimize or exclude undesired stimulation of other
anatomies. In addition, it may be appreciated that stimulation of other tissues are
also contemplated.
[0034] In most embodiments, neuromodulation comprises stimulation, however it may be appreciated
that neuromodulation may include a variety of forms of altering or modulating nerve
activity by delivering electrical stimulation directly to a target area. For illustrative
purposes, descriptions herein will be provided in terms of stimulation and stimulation
parameters, however, it may be appreciated that such descriptions are not so limited
and may include any form of neuromodulation and neuromodulation parameters.
System Overview
[0035] Referring to Figs. 8A-8D, an embodiment of a lead 100 (Fig. 8A) and delivery system
120, including a sheath 122 (Fig. 8B), stylet 124 (Fig. 8C) and introducing needle
126 (Fig. 8D), of the present invention is illustrated. In this embodiment, the lead
100 comprises a shaft 103 having a distal end 101 and four electrodes 102 disposed
thereon. It may be appreciated that any number of electrodes 102 may be present, including
one, two, three, four, five, six, seven, eight or more. In this embodiment, the distal
end 101 has a closed-end distal tip 106. The distal tip 106 may have a variety of
shapes including a rounded shape, such as a ball shape (shown) or tear drop shape,
and a cone shape, to name a few. These shapes provide an atraumatic tip for the lead
100 as well as serving other purposes. The lead 100 also includes a stylet lumen 104
which extends toward the closed-end distal tip 106.
[0036] Fig. 8B illustrates an embodiment of a sheath 122 of the present system. The sheath
122 has a distal end 128 which is pre-curved to have an angle α, wherein the angle
α is in the range of approximately 80 to 165 degrees. The sheath 122 is sized and
configured to be advanced over the shaft 103 of the lead 100 until a portion of its
distal end 128 abuts the distal tip 106 of the lead 100, as illustrated in Fig. 9.
Thus, the ball shaped tip 106 of this embodiment also prevents the sheath 122 from
extending thereover. Passage of the sheath 122 over the lead 100 causes the lead 100
to bend in accordance with the precurvature of the sheath 122. Thus, the sheath 122
assists in steering the lead 100 along the spinal column S and toward a target DRG,
such as in a lateral direction. It may be appreciated that the angle α may optionally
be smaller, such as less than 80 degrees, forming a U-shape or tighter bend.
[0037] Referring back to Fig. 8C, an embodiment of a stylet 124 of the present system is
illustrated. In this embodiment, the stylet 124 has a distal end 130 which is pre-curved
so that its radius of curvature is in the range of approximately 2.54 to 12.7 mm (0.1
to 0.5 inches). The stylet 124 is sized and configured to be advanced within the stylet
lumen 104 of the lead 100. Typically the stylet 124 extends therethrough so that its
distal end 130 aligns with the distal end 101 of the lead 100. Passage of the stylet
124 through the lead 100 causes the lead 100 to bend in accordance with the precurvature
of the stylet 124. Typically, the stylet 124 has a smaller radius of curvature, or
a tighter bend, than the sheath 122. Therefore, as shown in Fig. 10, when the stylet
124 is disposed within the lead 100, extension of the lead 100 and stylet 124 through
the sheath 122 bends or directs the lead 100 through a first curvature 123. Further
extension of the lead 100 and stylet 124 beyond the distal end 128 of the sheath 122
allows the lead 100 to bend further along a second curvature 125. When approaching
a target DRG, the second curvature allows the laterally directed lead 100 to now curve
around toward the target DRG, such as along the nerve root angulation. This two step
curvature allows the lead 100 to be successfully positioned so that at least one of
the electrodes 102 is on, near or about the target DRG, particularly by making a sharp
turn along the angle θ. In addition, the electrodes 102 are spaced to assist in making
such a sharp turn.
[0038] Thus, the lead 100 does not require stiff or torqueable construction since the lead
100 is typically not torqued or steered by itself. The lead 100 is positioned with
the use of the sheath 122 and stylet 124 which direct the lead 100 through the two
step curvature. This eliminates the need for the operator to torque the lead 100 and
optionally the sheath 122 with multiple hands. This also allows the lead 100 to have
a lower profile and smaller diameter, as well as a very soft and flexible construction.
This, in turn, minimizes erosion, irritation of the neural tissue and discomfort created
by pressure on nerve tissue, such as the target DRG and/or the nerve root, once the
lead 100 is implanted. In addition, such a soft and flexible lead 100 will minimize
the amount of force translated to the distal end of the lead 100 by body movement
(e.g. flexion, extension, torsion).
[0039] Referring back to Fig. 8D, an embodiment of an introducing needle 126 is illustrated.
The introducing needle 126 is used to access the epidural space of the spinal cord
S. The needle 126 has a hollow shaft 127 and typically has a very slightly curved
distal end 132. The shaft 127 is sized to allow passage of the lead 100, sheath 122
and stylet 124 therethrough. In some embodiments, the needle 126 is 14 gauge which
is typically the size of epidural needles used to place conventional percutaneous
leads within the epidural space. However, it may be appreciated that other sized needles
may also be used, particularly smaller needles such as 15-18 gauge. Alternatively,
non-standardized sized needles may be used.
[0040] The needle is atraumatic so as to not damage the sheath 122 when the sheath 122 is
advanced or retracted. In some embodiments, the shaft 127 comprises a low friction
material, such as bright hypotubing, made from bright steel (a product formed from
the process of drawing hot rolled steel through a die to impart close dimensional
tolerances, a bright, scale free surface and improved mechanical properties. Other
materials include polytetrafluoroethylene (PTFE) impregnated or coated hypotubing.
In addition, it may be appreciated that needles having various tips known to practitioners
or custom tips designed for specific applications may also be used. The needle 126
also typically includes a luer fitting 134, such as a Luer-Lok™ fitting, or other
fitting near its proximal end. The luer fitting 134 is a female fitting having a tabbed
hub which engages threads in a sleeve on a male fitting, such as a syringe. The needle
126 may also have a luer fitting on a side port, so as to allow injection through
the needle 126 while the sheath 122 is in the needle 126. In some embodiments, the
luer fitting is tapered to allow for easier introduction of a curved sheath into the
hollow shaft 127.
Delivery Methods
[0041] The above described delivery system 120 is used for epidural delivery of the lead
100 through the patient anatomy toward a target DRG. Thus, embodiments of epidural
delivery methods are described herein. In particular, such embodiments are described
and illustrated as an antegrade approach. It may be appreciated that, alternatively,
the devices and systems of the present invention may be used with a retrograde approach
or a contralateral approach. Likewise, at least some of the devices and systems may
be used with a transforaminal approach, wherein the DRG is approached from outside
of the spinal column. Further, the target DRG may be approached through the sacral
hiatus or through a bony structure such as a pedicle, lamina or other structure.
[0042] Epidural delivery involves accessing the epidural space. The epidural space is accessed
with the use of the introducing needle 126, as illustrated in Fig. 11. Typically,
the skin is infiltrated with local anesthetic such as lidocaine over the identified
portion of the epidural space. The insertion point is usually near the midline M,
although other approaches may be employed. Typically, the needle 126 is inserted to
the ligamentum flavum and a loss of resistance to injection technique is used to identify
the epidural space. Referring to Fig. 12, a syringe 140 is then attached to the needle
126. The syringe 140 may contain air or saline. Traditionally either air or saline
has been used for identifying the epidural space, depending on personal preference.
When the tip of the needle 126 enters a space of negative or neutral pressure (such
as the epidural space), there will be a "loss of resistance" and it will be possible
to inject through the syringe 140. At that point, there is now a high likelihood that
the tip of the needle 126 has entered the epidural space. Further, a sensation of
"pop" or "click" may be felt as the needle breaches the ligamentum flavum just before
entering the epidural space. In addition to the loss of resistance technique, realtime
observation of the advancing needle 126 may be achieved with a portable ultrasound
scanner or with fluoroscopy. Likewise, a guidewire may be advanced through the needle
126 and observed within the epidural space with the use of fluoroscopy.
[0043] Once the needle 126 has been successfully inserted into the epidural space, the syringe
140 is removed. The stylet 124 is inserted into the lead 100 and the sheath 122 is
advanced over the lead 100. The sheath 122 is positioned so that its distal end 128
is near or against the distal tip106 of the lead 100 causing the lead 100 to follow
the curvature of the sheath 122. The stylet 124, lead 100 and sheath 122 are then
inserted through the needle 126, into the epidural space, as illustrated in Fig. 13.
Referring to Fig. 14, the distal end 132 of the needle 126 is shown passed through
the ligamentum flavum L and the assembled sheath 122/lead 100/stylet 124 is shown
emerging therefrom. The rigidity of the needle 126 straightens the more flexible sheath
122 as it passes therethrough. However, upon emergence, the sheath 122 is allowed
to bend along or toward its precurvature as shown. In some embodiments, the shape
memory of the sheath 122 material allows the sheath 122 to retain more than 50% of
its precurved shape upon passing through the needle 126. Such bending assists in steering
of the lead 100 within the epidural space. This is particularly useful when using
a retrograde approach to navigate across the transition from the lumbar spine to the
sacral spine. The sacrum creates a "shelf" that resists ease of passage into the sacrum.
The precurved sheath 122 is able to more easily pass into the sacrum, reducing operating
time and patient discomfort.
[0044] Referring to Fig. 15, the assembled sheath 122/lead 100/stylet 124 is advanced within
the epidural space toward a target DRG. Steering and manipulation is controlled proximally
and is assisted by the construction of the assembled components and the precurvature
of the sheath 122. In particular, the precurvature of the sheath 122 directs the lead
100 laterally outwardly, away from the midline M of the spinal column. Fig. 16 illustrates
the assembled sheath 122/lead 100/stylet 124 advanced toward the target DRG with the
precurvature of the sheath 122 directing the lead 100 laterally outwardly.
[0045] Referring to Fig. 17, the lead 100/stylet 124 is then advanced beyond the distal
end 128 of the sheath 122. In some embodiments, the lead 100 extends approximately
2.54-7.62 cm (1-3 inches) beyond the distal end 128 of the sheath 122. However, the
lead 100 may extend any distance, such as less than 2.54 cm (1 inch), 0.64-7.62 cm
(0.25-3 inches), or more than 7.62 cm (3 inches). Likewise, the sheath 122 may be
retracted to expose the lead 100, with or without advancement of the lead 100. This
may be useful when advancement of the lead 100 is restricted, such as by compression
of the foraminal opening. The curvature of the stylet 124 within the lead 100 causes
the lead 100 to bend further, along this curvature. This allows the laterally directed
lead 100 to now curve around toward the target DRG along the nerve root angulation.
This two step curvature allows the lead 100 to be successfully steered to position
at least one of the electrodes 102 on, near or about the target DRG. In addition,
the ball shaped distal tip 106 resists trauma to the anatomy within the spinal column,
such as the dural sac, ligaments, blood vessels, and resists imparting trauma to the
DRG as the lead 100 is manipulated and advanced into place. Once desirably positioned,
the sheath 122 and stylet 124 are typically removed leaving the lead 100 in place.
However, optionally, the stylet 124 may be left within the lead 100 to stabilize the
lead 100, to assist in maintaining position and to resist migration. The DRG may then
be stimulated by providing stimulation energy to the at least one electrode 102, as
illustrated by energy ring 140 in Fig. 17. It may be appreciated that multiple electrodes
may be energized to stimulate the target DRG. It may also be appreciated that the
electrodes may be energized prior to removal of the stylet 124 and/or sheath 122,
particularly to ascertain the desired positioning of the lead 100. It may further
be appreciated that the sheath 122 may be retracted to expose the lead 100 rather
than advancing the lead 100 therethrough.
[0046] The same needle 126 can then be used to position additional leads within the epidural
space. Again, a stylet 124 is inserted into a lead 100 and a sheath 122 is advanced
over the lead 100. The sheath 122 is positioned so that its distal end 128 is near
or against the distal tip106 of the lead 100 causing the lead 100 to follow the curvature
of the sheath 122. The assembled stylet 124/lead 100/sheath 122 is then inserted through
the needle 126, into the epidural space, as illustrated in Fig. 18. The rigidity of
the needle 126 straightens the more flexible sheath 122 as it passes therethrough.
And, upon emergence, the sheath 122 is allowed to bend along its precurvature as shown.
This creates an atraumatic exit of the stylet 124/lead 100/sheath 122 out of the needle
126 since such curvatures resist any directed force into the dura layer of the spinal
cord. This also assists in steering of the lead 100 within the epidural space.
[0047] Referring to Fig. 19, the assembled sheath 122/lead 100/stylet 124 is advanced within
the epidural space toward another or second target DRG. In this embodiment, the second
target DRG is on an opposite side of the spinal column from the first target DRG.
Again, the precurvature of the sheath 122 can be used to steer the lead 100 and direct
the lead 100 laterally outwardly, away from the midline M of the spinal column. Thus,
DRGs on each side of the spinal column can be accessed by manipulation of the sheath
122 while entering the epidural space from the same insertion point. Fig. 20 illustrates
the assembled sheath 122/lead 100/stylet 124 advanced toward the second target DRG
with the precurvature of the sheath 122 directing the lead 100 laterally outwardly.
[0048] The lead 100/stylet 124 is then advanced beyond the distal end 128 of the sheath
122. Again, the curvature of the stylet 124 within the lead 100 causes the lead 100
to bend further, along this curvature. This allows the laterally directed lead 100
to now curve around toward the target DRG along the nerve root angulation. This two
step curvature allows the lead 100 to be successfully steered to position at least
one of the electrodes 102 on, near or about the target DRG. Once desirably positioned,
the sheath 122 and stylet 124 are removed leaving the lead 100 in place, as illustrated
in Fig. 21. The DRG may then be stimulated by providing stimulation energy to the
at least one electrode 102, as illustrated by energy rings 140 in Fig. 21. Again,
it may be appreciated that multiple electrodes may be energized to stimulate the target
DRG. It may also be appreciated that the electrodes may be energized prior to removal
of the stylet 124 and/or sheath 122, particularly to ascertain the desired positioning
of the lead 100.
[0049] It may be appreciated that any number of leads 100 may be introduced through the
same introducing needle 126. In some embodiments, the introducing needle 126 has more
than one lumen, such as a double-barreled needle, to allow introduction of leads 100
through separate lumens. Further, any number of introducing needles 126 may be positioned
along the spinal column for desired access to the epidural space. In some embodiments,
a second needle is placed adjacent to a first needle. The second needle is used to
deliver a second lead to a spinal level adjacent to the spinal level corresponding
to the first needle. In some instances, there is a tract in the epidural space and
the placement of a first lead may indicate that a second lead may be easily placed
through the same tract. Thus, the second needle is placed so that the same epidural
tract may be accessed. In other embodiments, a second needle is used to assist in
stabilizing the tip of a sheath inserted through a first needle. In such embodiments,
the second needle is positioned along the spinal column near the target anatomy. As
the sheath is advanced, it may use the second needle to buttress against for stability
or to assist in directing the sheath. This may be particularly useful when accessing
a stenosed foramen which resists access.
[0050] Fig. 22 illustrates a plurality of leads 100 positioned within the epidural space,
each lead 100 stimulating a different DRG. In this example, the DRGs are on multiple
levels and on both sides of the spinal column. The proximal ends of the leads 100
are connected with an IPG (shown in part) which is typically implanted nearby.
[0051] Thus, delivery of the lead 100 of the present system through the patient anatomy
toward a target DRG involves more potential challenges than delivery of conventional
spinal cord stimulator leads. For example, one significant challenge is steering the
lead 100 within the epidural space, particularly laterally toward the target DRG and
curving the lead 100 through the nerve root sleeve angulation to position at least
one of the electrodes 106 on, near or about the DRG. In addition, such leads 100 should
be atraumatic and resist kinking, migration fracture or pullout while implanted. Therefore,
significant floppiness and flexibility is desired. However, a more flexible lead can
be more difficult to manipulate. To overcome these conflicting challenges, a variety
of design features have been incorporated into the devices.
Lead and Delivery Devices
[0052] As described above, the present invention includes a variety of devices, including
one or more leads 100 and a delivery system 120, including a sheath 122, stylet 124
and introducing needle 126.
[0053] In some embodiments, the introducing needle 126 is a standard epidural access device
used commonly with an anti-coring stylet. Such needles 126 are typically comprised
of stainless steel and have an atraumatic tip to prevent insertion through the spinal
dural sac. In some embodiments, the introducing needle is a 14 gauge thin-wall, however
it may be appreciated that other sized needles may be used, particularly smaller diameter
needles.
[0054] The sheath 122, lead 100 and stylet 124 are all passable through the needle 126 for
introduction to the epidural space without damage to the needle 126 or to the devices
passed therethrough. Thus, access can be achieved through a single entry point and
the devices can be advanced, retracted, removed and reinserted through the needle
126 with ease and without irritation, injury or disruption to the tissues surrounding
the entry point. This provides a significant improvement over conventional delivery
systems which recommend introduction of devices using a Seldinger Technique. When
using the Seldinger Technique, a guidewire is passed through the introducing needle
and the needle is withdrawn. A conventional delivery sheath is then advanced over
the guidewire into the epidural space. The guidewire is then removed and the sheath
is used as a conduit for delivery of devices to the epidural space. However, the tip
of the sheath tends to fold and irritate the patient during placement through the
ligamentum flavum. Also, the conventional sheath lacks the column strength to push
through calcified or difficult to pass tissue. Further, the introduction and removal
of each of these devices increases the risk of dural puncture and patient discomfort.
Consequently, conventional sheaths are typically abandoned in favor of directly advancing
the lead into the epidural space. This may be possible since conventional lead placement
simply involves linear advancement along the spinal column without significant steering,
bending or curving and conventional sheaths provide no guiding or steering capability
anyway. Conventional sheaths are also incapable of fitting through a conventional
introducing needle due to their size and wall thickness. Thus, practitioners are left
with manipulating the lead itself.
Sheath
[0055] The sheath 122 of the present system comprises a hollow tube having a stiffness which
allows advancement along the epidural space. In some embodiments, such stiffness has
a minimum of approximately 4.48 kPa (0.65 lbs·in
2) and a maximum of approximately 15.5 kPa (2.25 lbs·in
2). Thus, in some embodiments, the sheath 122 has a stiffness of approximately 12.48
kPa (1.81 lbs·in
2).
[0056] In most embodiments, the sheath 122 has a preformed or preset bend near its distal
end 128, as illustrated in Fig. 23A, to assist in accessing the target anatomy. In
some embodiments, the bend has an angle α of approximately 15-165 degrees, however
any suitable angle may be used. The bend can also be characterized by the lateral
distance D from the distal tip to the outer surface of the shaft, as illustrated in
Fig. 23A. In some embodiments, the distance D is approximately 0.76-9.53 mm (0.030-0.375
inches). In some embodiments, the sheath 122 is sized and shaped for particular types
of delivery, such as antegrade, retrograde, and contralateral approaches, to name
a few. In some embodiments, an antegrade sheath (configured for antegrade delivery)
has a bend with an angle α of approximately 90-110 degrees and a distance D of approximately
8.25-9.53 mm (0.325-0.375 inches). Bends having an angle α less than or equal to150
degrees and a distance D of greater than or equal to 5.72 mm (0.225 inches) typically
improve the ease of delivery when using an antegrade approach to the DRG. In some
embodiments, an alternate sheath (configured for retrograde or contralateral delivery)
has a bend with an angle α of approximately 130-150 degrees and a distance D of approximately
1.14-2.4 mm (0.045-0.095 inches). Bends having an angle α less than or equal to 165
degrees and a distance D of greater than or equal to 0.76 mm (0.030 inches) typically
improve the ease of delivery when using a retrograde or contralateral approach to
the DRG. The sheath 122 can be rigid enough to guide the lead 100/stylet 124 without
the sheath 122 significantly deflecting. Alternatively, the sheath 122 may be more
flexible to allow increased steering or guiding through the anatomy.
[0057] Typically, the sheath 122 is comprised of a polymer, such as polyimide, or polyetheretherketone
(PEEK). In preferred embodiments, the sheath 122 is comprised of a plastic material,
such as a thermoset and/or thermoplastic material. Polyimide is preferred due to the
thinness of its walls while retaining high strength, superior shape memory and shape
retention. Polyimide can also be straightened for passage through the introducing
needle 126 without kinking. In some embodiments, the sheath 122 is comprised of polyimide
material having a wall thickness in the range of approximately 0.051-0.152 mm (0.002-0.006
inches), more particularly approximately 0.076-0.152 mm (0.003-0.006 inches). It may
be appreciated that other materials may be used provided the resulting sheath has
an appropriate stiffness to allow advancement along the epidural space, while having
a wall-thickness thin enough to allow passage of the sheath and lead through an introducing
needle to the epidural space, and while having a sufficiently low coefficient of friction
to allow desirable passage of the lead therethrough. Further, the resulting sheath
should be kink-resistant and formable into a desired shape. Examples of other materials
potentially meeting these criteria include nylon, polycarbonate, acrylonitrile butadiene
styrene (ABS), Polyethylene terephthalate (PET) and Pebax, to name a few.
[0058] Typically, the sheath 122 is comprised of a single stiffness or unidurometer material.
This is possible because the sheath 122, lead 100 and stylet 124 are introduced together
to the epidural space, sharing the delivery workload. In particular, since the lead
100 and stylet 124 substantially fill the inner diameter of the sheath 122, strength
and kink resistance are bolstered for delivery robustness. In contrast, if the sheath
122 were introduced alone, stiffness transitions, such as durometer/materials changes,
or reinforcements, such as braiding, may be needed for kink resistance. However, it
may be appreciated that sheath 122 may optionally be comprised of a reinforced polymer,
such as a braided polymer, or may be comprised of a construct of various materials.
For example, the tip of the sheath 122 may be comprised of a differing material or
a thinner material to create a less traumatic or an atraumatic tip. Such a tip may
be more flexible than the remainder of the sheath which provides increased torqueability
and pushability. Further it may be appreciated that the sheath 122 may optionally
be comprised of a flexible metal or metal/polymer construct.
[0059] Delivery of the lead 100, stylet 124 and sheath 122 together also provides a number
of other benefits. For example, preloading of the lead 100, stylet 124 and sheath
122 and simultaneous delivery eliminates multiple steps and complications associated
with separate introduction of each device. Further, matching the coaxial shapes of
the lead 100, stylet 124 and sheath 122 create steerability and lead control without
the need for stiffening lead construction and without sacrificing lead flexibility
and profile. In addition, preloading of the sheath 122 with a lead 100 having a ball
shaped distal tip 106 allows the sheath 122 to have a comparatively hard or sharp
tip because it is shielded by the atraumatic ball shape of the distal tip 106 of the
lead 100. Thus, the practitioner may be less concerned with traumatizing surrounding
tissue during delivery in comparison to advancing a traditional open-tipped sheath.
However, it may be appreciated that the distal end of the sheath 122 may optionally
be formed from a soft material, such as Pebax, to create a more atraumatic tip for
the sheath 122 itself. In such instances, the sheath 122 may optionally be used with
a lead 100 without a ball shaped distal tip 106 and may be loaded on the lead 100
either from the proximal or distal ends of the lead 100.
[0060] The ball shaped distal tip 106 of the lead 100 also provides tactile feedback when
retracted against the sheath 122. Such feedback allows the practitioner to tactilely
determine the relative position of the lead 100 to the sheath 122. It may be appreciated
that other mechanisms may be used to register the distal tip 106 of the lead 100 against
the sheath 122, such as slots, pins, and bands, to name a few. Alternatively, such
registering may be achieved near the proximal end of the lead 100 and sheath 122.
[0061] In some embodiments, the sheath 122 includes a chamfer or flared edge near its distal
end to assist in retraction of the lead 100 therein. In some instances, the chamfer
comprises radiusing of the inside of the sheath 122 near the distal end by, for example,
approximately 0.051 mm (0.002 inches) or more. Such radiusing provides an atraumatic,
smooth edge to funnel the lead 100 and electrodes 102 thereon into the sheath 122.
Likewise, a flared edge assists in allowing the lead 100 and electrodes 102 thereon
to pass into the sheath 122 without hooking on the distal end of the sheath 122. This
reduces any risk of damage to the lead 100, such as due to the electrodes 102 catching
on the sheath 122, and reduces procedure time since the physician can reposition the
device without removing the entire system.
[0062] In most embodiments, the sheath 122 also includes a hub 162, such as illustrated
in Fig. 23A, near its proximal end wherein the hub 162 assists in manipulation of
the sheath 122. The torsional rigidity of the sheath 122 allows the sheath 122 to
be torqued by rotation of the hub 162. In some embodiments, the hub 162 also provides
indication of the direction of the bend. This assists in steering the lead 100 with
or without the aid of visualization. In instances where visualization is used, such
as fluoroscopy, an embodiment of the sheath 122 may be used which has a radiopaque
marker 164 near its distal end 128. Alternatively, the sheath 122 may be marked with
radiopaque stripes, such as along the distal end 128 or along the length of the sheath
122. Likewise, the sheath 122 may be marked with radiopaque marker bands, such as
tungsten or platinum marker bands, since the wall thickness of the sheath 122 is not
limited by the epidural space.
[0063] Alternatively or in addition, the sheath 122 may be loaded with radiopaque material
to provide radiopacity along the distal end 128 or along its length. In any case,
any suitable radiopaque material may be used, such as tungsten or barium sulfate.
In some embodiments, the sheath 122 is less radiopaque than the lead 100 so that the
practitioner can maintain visualization of the lead 100 and can visualize the interaction
of the sheath 122 and lead 100 together. Or, in some embodiments, the sheath 122 and
lead 100 each have radiopaque markers at their respective ends so that the practitioner
is aware of their locations, both within the anatomy and in relation to each other.
Visualization of the lead 100 and sheath 122 is particularly useful for the methods
disclosed herein which typically involve manipulation of the devices in three dimensions,
such as movement in and out of different planes, as opposed to conventional SCS lead
placement which occurs in two dimensions.
[0064] Such movement of the lead 100, including curving of the lead 100 through the nerve
root sleeve angulation, typically involves more and greater bends (bends having lower
radii) to the distal end 101 of the lead 100 than conventional leads used in standard
SCS therapy. Consequently, embodiments of the lead 100 of the present system have
a variety of design features to accommodate such bending and increased manipulation
demands. Typically, the lead 100 has a more flexible distal end 101 than conventional
leads and has a lower diameter. Most embodiments of the lead 100 also minimize constraints
on internal components and utilize low stiffness materials. Such features ease manipulation,
reduce any possibility of trauma to the DRG and resist lead migration since less load
and strain from the body will be translated to the distal end of the lead itself.
[0065] Referring to Fig. 23B, in some embodiments the hub 162 includes a locking cap 165
which is used to lock the lead 100 in position within the sheath 122. Such locking
may assist in reducing movement of the lead 100 during manipulation of the sheath
122. In one embodiment, the locking cap 165 has a threaded elongated portion 166 which
engages with threads within the hub 162. The locking cap 165 also has an aperture
168 which aligns with a lumen extending through the sheath 122. The lead 100 is advanceable
through the aperture 168 and into the lumen of the sheath 122. When the lead 100 is
desirably positioned, the lead 100 may be locked in place by rotating the locking
cap 165 which advances the threaded elongated portion 166 into the hub 162 and compresses
a gasket 170. The gasket 170 may be comprised of any flexible material, such a silicone.
Compression of the gasket 170 causes the gasket 170 to engage the lead 100, thereby
locking the lead 100 in place by frictional forces. Optionally, the hub 162 may include
an injection port 172 which may be used to inject a desired medium, such as contrast,
saline or other fluids.
[0066] Figs. 24A-24E illustrate an embodiment of a lead 100 of the present system. Fig.
24A provides a perspective view of an embodiment of a lead 100. The lead 100 comprises
a shaft 103 having a distal end 101 and a proximal end 105. In this embodiment, the
shaft 103 comprises a single lumen tube 172 formed from an extruded polymer, such
as urethane. Fig. 24B provides a cross-sectional view of the shaft 103 of Fig. 24A.
Typically, the tube 172 has an outer diameter in the range of approximately 1.02-1.27
mm (0.040-0.050 inches), a wall thickness in the range of approximately 0.127-0.254
mm (0.005-0.010 inches) and a length of approximately 30.48-76.2 cm (12-30 inches),
however such dimensions serve only as an example. For instance, in other embodiments,
the tube 172 has an outer diameter in the range of approximately 0.71-1.27 mm (0.028-0.050
inches), a wall thickness in the range of approximately 0.076-0.254 mm (0.003-0.010
inches) and a length of approximately 30-120cm. It may be appreciated that other materials
may be used, such as silicone or other commonly used implantable polymers.
[0067] Referring to Fig. 24B, the lead 100 also includes a stylet tube 174 disposed within
the single lumen tube 172. The stylet tube 174 forms a stylet lumen 176 and isolates
the stylet 124 from the other components of the lead 100. The stylet tube 174 also
provides a smooth or lubricious surface against which the stylet 124 passes during
insertion and retraction. Such lubriciousness is desirable to resist jamming or hang-ups
of the highly curved stylet 124 within the lead 101. In addition, the lubricious surface
reduces the effects on delivery of contamination by bodily fluids. The stylet tube
174 may also provide tensile strength to the lead 100 during delivery.
[0068] In some embodiments, the stylet tube 174 is comprised of polyimide. Polyimide is
a biocompatible, high strength, smooth, flexible material. Smoothness is provided
by the means of manufacturing, and adequate lubriciousness is provided by the low
coefficient of friction (0.7) of the material. In some embodiments the polyimide is
combined with Teflon to lower the coefficient of friction while maintaining high strength.
Because polyimide is high strength, tough and smooth, stylets 124 having highly radiused
bends are easier to introduce and manipulate therein without the stylet 124 catching,
hanging, jamming or piercing into or through the sides of the stylet tube 174 as may
occur with some polymers. In some embodiments, the polyimide material is loaded with
a strengthening material to increase its overall tensile strength. Examples of such
strengthening materials include engineering fibers, such as Spectra® fiber, Vectran™
fiber and Kevlar® fiber, to name a few.
[0069] The physical qualities of the polyimide material also allows the stylet lumen walls
to be very thin, such as approximately 0.0254 mm (0.001 inches) or less, which helps
to minimizes the overall diameter of the lead 100. Such thinness may not be achieved
with the use of some other biocompatible polymer materials with equivalent strength
and resistance to buckling.
[0070] In other embodiments, the stylet tube 174 is comprised of polyetheretherketone (PEEK).
PEEK is a biocompatible, high strength, and smooth material, and in a thin-walled
tube configuration is a sufficiently flexible material. Smoothness is provided by
the means of manufacturing, and adequate lubriciousness is provided by the fairly
low coefficient of friction (0.35) of the material. Because PEEK is high strength,
tough and smooth, stylets 124 having highly radiused bends are easier to introduce
and manipulate therein without the stylet 124 catching, hanging, jamming or piercing
into or through the sides of the stylet tube 174 as may occur with some polymers.
[0071] And, in other embodiments, the stylet tube 174 is comprised of other polymers, such
as Polyethylene Terephthalate (PET) film (also known as polyester or Mylar), or other
materials, such as a metal tube, a flexible metal tube (such as formed from nitinol),
a laser-cut metal tube, a spring or coil (such as a metal close-coiled spring), or
a combination of materials and forms.
[0072] As mentioned above, the stylet tube 174 may have a lubricious surface, such as a
coating or embedded layer, along at least a portion of the stylet lumen 176 to provide
the desired lubriciousness. An example of such a surface is a polytetrafluoroethylene
(PTFE) or parylene coating. The tube 174 may be comprised of a material such as polyimide
and additionally coated, or the tube 174 may be comprised of a less lubricious material
and coated to attain the desired lubricity. Such a coating may be particularly useful
when the shaft 103 is comprised of a multi-lumen extrusion.
[0073] It may be appreciated that alternatively, a multi-lumen tube may be used for the
shaft 103 of the lead 100, or a combination of multi-lumen and single lumen tubing.
When such a multi-lumen tube is formed from an extruded polymer, various other components
of the lead 100 may be coextruded with the multi-lumen tube (such as conductor cables,
a stylet tube and/or a tensile wire described herein below). Fig. 24F illustrates
an embodiment of a shaft 103 of the lead 100, wherein the shaft 103 comprises a 5
lumen extrusion. Four of the lumens house conductor cables 182; each conductor cable
182 loosely filling each lumen. And, one larger lumen serves as the stylet lumen 176.
Typically, the stylet lumen 176 includes a lubricious surface 175, such as a coating
or embedded layer, along at least a portion of the stylet lumen 176 to provide the
desired lubriciousness. In addition a tensile element 188 may be co-extruded with
the extrusion, as shown, or the tensile element may be loosely embedded in a sixth
lumen of the extrusion. The ability to per-insert a cable or element loosely into
a small lumen is a specialized aspect that allows the lead 100 increased flexibility.
And, although the lead 100 is typically curved by devices such as a stylet, the distal
end of the multi-lumen tube may optionally be thermally precurved to assist in such
curvatures.
[0074] Referring back to Fig. 24A, the lead 100 also includes at least one electrode 102.
In this embodiment, the lead 100 includes four electrodes 102 disposed along its distal
end 101. Typically, the electrodes 102 are comprised of platinum or platinum/iridium
alloy. In this embodiment, the electrodes 102 have a ring shape, extending around
the shaft 103, and have an outer diameter approximately equal to the outer diameter
of the shaft 103. In some embodiments, the electrodes have a wall thickness of approximately
0.051-0.102 mm (0.002-0.004 inches) and a length of approximately 0.76-1.52 mm (0.030-0.060
inches) or greater. It may be appreciated that the shaped distal tip 106 of the lead
100 may be formed from the most distal electrode. And, it may be appreciated a proximal
end cap (described below) may serve as the most proximal electrode.
[0075] The lead 100 also includes at least one electrical contact 180 disposed near its
proximal end 105 which is removably connectable with a power source, such as an implantable
pulse generator. In this embodiment, the lead 100 includes a corresponding electrical
contact 180 for each electrode 102. Electrical energy is transmitted from the electrical
contact 180 to the corresponding electrode 102 by a conductor cable 182 which extends
therebetween. Thus, the cables 182 are typically approximately 45.7-55.9 cm (18-22
inches) long, but are typically up to 120 cm (47.24 inches) long.
[0076] Referring to Fig. 24B, the conductor cables 182 extend through a space 186 between
the stylet tube 174 and the single lumen tube 172. The cables 182 may be comprised
of any suitable material, preferably multiple Drawn Filled Tube (DFT) strands each
comprising a high strength outer layer of cobalt-chrome alloy and a high conductivity
core of silver, platinum or platinum/iridium alloy. Typically, the cables 182 are
electrically insulated by a thin layer of material, such as polytetrafluoroethylene
(PTFE) or perfluoroalkoxy (PFA). Consequently, the cables 182 typically have an outer
diameter of approximately 0.15 mm (0.006 inches). However, it may be appreciated that
the cables 182 may be uncoated or uninsulated when the shaft 103 is comprised of a
multi-lumen extruded tube and each cable 182 extends through a dedicated lumen, or
alternatively, when the cables are embedded in the wall of the extruded tube. Another
type of cable construction can include a combination of high strength strands and
high conductivity strands. Alternatively, only high strength strands, such as cobalt-chrome
alloy or stainless steel, may be used. In such embodiments, resistance may be decreased
by enlarging the cable cross section.
[0077] Each cable 182 is joined to an electrode 102 and a corresponding electrical contact
180 by a suitable method, such as welding, brazing, soldering or crimping, to name
a few. The joining process provides an electrical contact between the cable and the
electrode, and also resists separation of the cable from the electrode due to any
tensile forces that the lead may be subjected to during or after implantation. Therefore,
the joining process should be electrically low resistance and be physically high strength.
A high strength joint is enabled by ensuring that neither of the materials being joined
are degraded by the joining process, in addition to having sufficient surface area,
compatible materials and other factors. In preferred embodiments, such joining is
achieved by welding which is performed using a YAG laser from the outside of the electrode
102, through the electrode wall. The laser joins the cable 182 with the inner surface
of the electrode 102. In some embodiments, the weld melts the electrode alloy so that
the melt at least partially penetrates the strands of the cable 182 which are touching
the inner surface of the electrode 102. It is desirable that little melting of the
cable 182 (e.g. strands of DFT) occurs because the strength properties of cobalt-chrome
alloy may decrease when it is overheated due to welding.
[0078] In preferred embodiments, each electrode 102 is welded to the conductor cable 182
with two welds. The two welds are approximately 0.51-1.02 mm (0.020-0.040 inches)
apart along the electrode 102. When stranded cables are used, twisting of the strands
between the two welds captures a different set of strands in each weld. After the
welding is complete, the strands at the end of the cable 182 are laser fused together
by cutting the cable 182 to length near the end of the electrode 102. It may be appreciated
that the same methods may be used to weld the cable 182 to the corresponding electrical
contact 180.
[0079] This welding method ensures that many strands are captured by the welds to connect
the cable 182 with the electrode 102 or electrical contact 180 without overheating
the cable material. However, it may be appreciated that a single weld may be used.
In any case, fusing the end of the cable 182 after welding can increase the load sharing
of the strands and the breaking strength of the cable weld. Thus, even those strands
that are not directly welded to the electrode 102 or electrical contact 180 can at
least partially share the tensile load through the fusing operation.
[0080] It may be appreciated that, in some embodiments, at least some of the cables 182
are comprised of a single wire. In such instances, a single weld may be sufficient.
In other embodiments, the cables 182 are formed together in a composite cable. Optionally,
the cables 182 may be embedded in the wall of the shaft 103.
[0081] It may also be appreciated that the electrodes 102 may have other forms. For example,
in some embodiments, at least one electrode 102 is comprised of a plurality of elements
that are electrically connected to each other. In other embodiments, at least one
electrode 102 extends partially around the shaft of the lead 100 so as to impart a
directional field. In still other embodiments, at least one electrode has a hollow
cylinder shape wherein one or more features are cut from or through its surface. This
may allow extension of the length of the electrode without increasing its surface
area. Such longer electrodes may reduce the effects of lead migration. Other embodiments
include diverse electrode shapes and edge geometries in order to affect the level
and variation of current density to optimize the effect of the energy on the target
anatomy. It may also be appreciated that at least one electrode 102 may have a composite
structure or be comprised of pyrolite carbon which provides for surface geometry increases.
[0082] In some embodiments, the lead 100 also includes a tensile element 188, as illustrated
in Fig. 24B. The tensile element 188 extends through the space 186 between the stylet
tube 174 and the single lumen tube 172. In some embodiments, the tensile element 188
comprises a single strand wire of suitable material, such as cobalt-chrome alloy.
In such embodiments, the element 188 typically has a diameter of 0.102 mm (0.004 inches).
Optionally, the element 188 may have multiple diameters. For instance, the element
188 may have a larger diameter near the proximal end 105 (such as approximately 0.254
mm (0.010 inches)) and then neck down toward the distal end 101. This may increase
the ease of insertion of at least a portion of the proximal end 105 into the implantable
pulse generator yet maintain adequate flexibility in the distal end 101 of the lead
100 while retaining adequate tensile strength. It may be appreciated that in some
embodiments, more than one tensile element 188 may be used. And, in some embodiments
the tensile element 188 is comprised of other materials and forms such as metals,
polymers, stainless steel, braids, and cables, to name a few.
[0083] The element 188 typically extends from the distal end 101 to the proximal end 105
of the lead 100, however the element 188 may extend any desirable distance. The element
188 is fastened to portions of the lead 100 that allow the element 188 to absorb tensile
stress applied to the lead 100 during or after implantation. In particular, the element
188 is tighter or straighter than the conductor cables 182 so as to absorb the tensile
load first. Thus, the tensile element 188 is flexible at least near the distal end
101, but has adequate tensile strength (such as greater than or equal to 13.79 kPa
(2 lbf)) to guard the cables 182 and welds from breakage. This is preferable to the
conductor cables 182 and welds absorbing the tensile load and increases the tensile
strength of the lead 100. Such fastening may be achieved with welding, potting, crimping,
wrapping, insert molding or any suitable method.
[0084] In the embodiment of Fig. 24B, the stylet tube 174, the tensile element 188, and
the conductor cables 182 extend through the single lumen tube 172 and are free to
move therein. Typically, these components are fixed to the single lumen tube 172 near
its proximal and distal ends and the components are unattached therebetween. Thus,
as the lead 100 bends or curves during positioning, the stylet tube 174, the tensile
element 188, and the conductor cables 182 are each able to move somewhat independently
within the single lumen tube 172. Such movement allows greater flexibility in bending
and lower applied forces to achieve reduced curve radii in the lead 100. It may be
appreciated that the components may be fixed at other locations, allowing freedom
of movement therebetween. Likewise, it may be appreciated that the space 186 may optionally
be filled with potting material, such as silicone or other material.
[0085] In some embodiments, the lead 100 does not include a separate tensile element 188.
In such embodiments, the stylet tube 174 may be reinforced with longitudinal wires,
strips, coils, embedded braids or other elements to provide additional tensile strength.
[0086] As mentioned previously, the distal end 101 of the lead 100 has a closed-end distal
tip 106. The distal tip 106 may have a variety of shapes including a ball shape, as
shown. The shaped tip provides an atraumatic tip for the lead 100 as well as serving
other purposes, such as preventing the distal tip 106 from being withdrawn into the
sheath 122. This also serves as an atraumatic tip for the sheath 122. In some embodiments,
the diameter of the shaped distal tip 106 is approximately the same as the outer diameter
of the sheath 122. For example, in the instance of a ball shaped distal tip 106, if
the diameter of the sheath 122 is approximately 1.32-1.45 mm (0.052-0.057 inches),
the diameter of the ball may be 1.4-1.52 mm (0.055-0.060 inches). The ball is also
sized so as to be passable through the introducing needle 126. However, it may be
appreciated that the distal tip 106 may optionally be shaped to allow the lead 100
to be retracted into the sheath 122. For example, the lead 100 and the sheath 122
may have corresponding "keyed" features that allow certain rotations of the lead 100
to pass thru the sheath 122. Or, the lead 100 may include a mechanism which causes
the distal tip 106 to be reduced in diameter. Such a mechanism may be actuated at
the proximal end of the lead, such as by the stylet 124.
[0087] Fig. 24C illustrates a cross-sectional view of an embodiment of a distal tip 106
of a lead 100 having a ball shape, wherein the distal tip 106 is retracted against
the distal end of the sheath 122. In this embodiment, the tip 106 is molded from the
same material as the shaft 103, such as by a catheter tipping operation. However,
it may be appreciated that the ball shape may be formed from any variety of methods
and materials, such as silicone, UV adhesives, cyanoacrylates or any suitable material
that can be flowed into a shape and cured to maintain the shape. It may also be appreciated
that the ball shaped distal tip 106 may also have an additional distal atraumatic
feature, such as a silicone tip. Alternatively or in addition, the distal tip 106
may be configured to allow ingrowth of tissue. For example, the distal tip 106 may
be comprised of multifilament polymers.
[0088] In this embodiment, the tip 106 also includes an internal assembly 200, as illustrated
in Fig. 24C. Typically the internal assembly 200 is comprised of metal, such as cobalt-chrome
or stainless steel, or other suitable material. The internal assembly 200 acts as
a hard barrier that prevents the stylet 124 from protruding out the distal end 100
of the lead 100. In addition, the internal assembly 200 may serve as a mechanism of
attaching the stylet tube 174 to the single lumen tube 172. Further, the internal
assembly 200 may serve as an anchoring point for the tensile element 188. In addition,
when the internal assembly 200 is comprised of a radiopaque material, the assembly
may serve as a radiopaque marker under fluoroscopy.
[0089] It may be appreciated that in some embodiments the distal tip 106 is not closed-ended.
For example, the distal tip 106 may include a passageway to allow pressure relief
to aid in inserting or withdrawing the stylet 124. Likewise, it may be appreciated
that in some embodiments, the distal tip 106 does not include an internal assembly
200. In such embodiments, the stylet tube 174 may be attached to the single lumen
tube 172 by potting or other mechanisms.
[0090] In some embodiments, the lead 100 includes potting 190 between the stylet tube 174
and the single lumen tube 172, as illustrated in Fig. 24C. Examples of such potting
190 include silicone, other polymers, adhesive, or melting of the material which forms
the single lumen tube 172. Potting 190 may be disposed along the distal end 101, the
proximal end 105 or along the length of the lead 100. In some instances, the potting
190 provides additional resistance to failure due to such factors as electrical shorting
or weld breakage. Potting can also prevent migration of bodily fluids through portions
of the lead. Potting can also improve ease of insertion of the proximal end of the
lead into the pulse generator.
[0091] In some embodiments, the distal end of the lead 100 is overmolded or cast with polymer
or other suitable material to encapsulate the components, with the exception of the
outer surface of the electrodes.
[0092] Fig. 24D provides a side cut-away view a portion of the distal end 101 of the lead
100 of Fig. 24A. An electrode 102 is shown wrapped around the single lumen tube 172,
and a conductor cable 182, having a stripped end, is attached to the electrode 102.
The stylet tube 174 is shown extending through the single lumen tube 172. Likewise,
the tensile element 188 is shown extending alongside the stylet tube 174.
[0093] In some embodiments, the lead 100 includes a proximal end cap 200, such as illustrated
in Fig. 24E. The proximal end cap 200 is disposed on the proximal end 105 of the lead
100, as illustrated in Fig. 24A. In this embodiment, the end cap 200 comprises a clamping
ring 202 and a hollow shaft 204, wherein the shaft 103 of the lead 100 extends over
the hollow shaft 204 and abuts the clamping ring 202. The shaft 103 is attached to
the end cap 200 by suitable mechanisms, such as by adhesive, melting of the shaft
material, overmolding or by clamping with an external ring, to name a few. The end
cap 200 also includes a lumen 206 which connects with the stylet lumen 104 of the
lead 100. Thus, the stylet 124 is insertable through the lumen 206 and advanceable
therethrough. In some embodiments, the opening to the lumen 206 is beveled, as shown,
to assist in such insertion.
[0094] The clamping ring 202 provides a solid point against which an implantable pulse generator
connector block set screw may fixate, holding the lead 100 in place within the header
of the pulse generator. The end cap 200 may also serve as an anchoring point for the
tensile element 188. Likewise, the end cap 200 may be used to connect stylet tube
174 and the single lumen tube 172 together. Typically, the end cap 200 is comprised
of a metal, such as cobalt-chrome or stainless steel. However, the end cap 200 may
alternatively be comprised of a polymer, optionally with an embedded strength member
along the clamping ring 202 to resist the force of the set screw. In some embodiments,
the end cap 200 is used as an electrode. In such embodiments, the end cap 200 is connected
with a conductor cable 182 and an electrode 102 disposed on the distal end of the
lead 100.
Stylet
[0095] Figs. 25, 26A-26B illustrate embodiments of a stylet 124 of the present system. In
some embodiments, the stylet 124 is comprised of superelastic nitinol. Nitinol is
biocompatible and provides a variety of desirable features. For example, the nitinol
material is elastic enough to allow the stylet 124 to straighten when inserted into
a lead 100 and captured within a straight portion of the sheath 122. However, it is
able to recover its shape once the lead 100 is advanced past the distal end 128 of
the sheath 122, at which point the stylet 124 has enough bending stiffness to force
the distal end 101 of the lead 100 into a desired curve for delivery. In particular,
it forces the distal end 101 of the lead 100 to curve around toward the target DRG
along the nerve root angulation. This allows the lead 100 to be successfully steered
to position at least one of the electrodes 102 on, near or about the target DRG, particularly
by making a sharp turn along the angle θ of Fig. 7.
[0096] Typically, the stylet 124 has a diameter in the range of approximately 0.2-0.61 mm
(0.008-0.024 inches), preferably approximately 0.2-0.46 mm (0.008-0.018 inches). In
some embodiments, the stylet 124 has a diameter of 0.254 mm (0.010 inches), particularly
when used with a lead 100 having an outer diameter of 1.02 mm (0.040 inches). Superelastic
nitinol, especially in the 0.254 mm (0.010 inch) diameter range, has relatively low
stiffness which is beneficial for atraumatic guidance of the stylet 124/lead 100 combination
near nerve and other tissue. Thus, the stylet 124/lead 100 combination may tend to
be guided between anatomical layers rather than be forced through tissue.
[0097] Typically, the stylet 124 has a length that is approximately 1 cm longer than the
lead 100. In addition, the distal end 130 of the stylet 124 is preset into a curve.
Fig. 25 illustrates a stylet 124 having a primary curve X. The primary curve X may
be described in terms of an arch shape or half circle having a perimeter along which
the stylet 124 extends. Thus, a 180 degree primary curve X would be comprised of the
distal end of the stylet 124 extending along the entire half circle. A 90 degree primary
curve X would be comprised of the distal end of the stylet 124 extending half way
around the half circle. The primary curve X may be formed by the stylet 124 extending
up to 360 degrees, typically up to 270 degrees, more typically up to 180 degrees.
The embodiment of Fig. 25 illustrates a primary curve X formed by the distal end of
the stylet 124 extending 170 degrees along the perimeter of the half circle, wherein
the half circle has a radius of 6.35 mm (0.25 inches). In this embodiment, the distal
tip of the stylet 124 has a 2.54 mm (0.10 inch) straight section.
[0098] In some embodiments, the curve is comprised of a primary curve X and a secondary
curve Y. The embodiment of Fig. 26A illustrates a primary curve X formed by the distal
end of the stylet 124 extending 180 degrees along the perimeter of the half circle,
wherein the half circle has a radius of 6.35 mm (0.25 inches). In this embodiment,
stylet 124 also has a secondary curve Y which is proximal and adjacent to the primary
curve X. It may be appreciated, however, that no secondary curve Y may be present
(as in Fig. 25) or the secondary curve Y may be formed at any location along the stylet
124 and may not be adjacent to the primary curve X. Typically, the secondary curve
Y has a larger radius of curvature than the primary curve X. In this embodiment, the
secondary curve Y has a radius of curvature of 3.81 cm (1.5 inches).
[0099] In other embodiments, the primary curve X and/or secondary curve Y are compound curves.
A compound curve is comprised of two or more subcurves. For example, Fig. 26B illustrates
primary curve X comprised of a subcurve having a radius of curvature of 6.35 mm (0.25
inches) and another subcurve having a radius of curvature of 9.4 mm (0.37 inches).
Such compound curvatures allow for greater variety of overall shape. In this example,
the compound curvature creates a slightly wider primary curve X.
[0100] Overall, the primary curve X may be considered "U" shaped. It may be appreciated,
that other curve shapes may be used to increase ease of delivery or increase anchoring
of the lead 100 about the desired anatomy. Examples include a "V" shape, an "S" shape
or a coil, to name a few.
[0101] It may be appreciated that the stylet 124 is formed from other materials in other
embodiments, such as metals, alloys, polymers and stainless steel. Stainless steel
may be preferred with the lead 100 is to be delivered in a relatively straight or
straighter configuration. The stylet 124 may be supplied in a straight or pre-bent
configuration. Likewise, the stylet 124 may be bent by the practitioner prior to insertion
into the lead 100.
[0102] In some embodiments, the distal tip of the stylet 124 is rounded or otherwise formed
to resist embedding into the wall of the stylet tube 174 or damaging the stylet tube
174 during insertion. Likewise, in some embodiments, the stylet 124 is coated with
polytetrafluoroethylene (PTFE), parylene or other coating material to increase lubricity.
This eases insertion of the stylet 124 through the stylet tube 174 and resists jamming
or hangups. In addition, a lubricious coating can increase tactile feedback of the
stylet motion within the lead 100. As mentioned above, such lubricity may be provided
by the stylet tube 174 itself or a coating along the stylet lumen 176, however such
coating of the stylet 124 may be used alternatively or in addition.
[0103] In some embodiments, the stylet 124 includes a gripping device near its proximal
end. The gripping device allows the stylet 124 to be more easily or more ergonomically
grasped for torquing the stylet 124. Such torquing changes the steering direction
of the distal end 130 of the stylet 124. The gripping device may be fixedly or removably
attached to the stylet 124. In some embodiments, the gripping device also indicates
the direction of the curvature of the distal end 130.
[0104] It may be appreciated that more than one stylet 124 may be inserted into a lead 100,
particularly into the same stylet tube 174. In such instances, each stylet 124 may
have a different bend geometry or stiffness and manipulation of the stylets 124 could
allow for increased steering capability. Likewise, the lead 100 may include more than
one stylet tube 174 or insertion of multiple stylets 174.
[0105] Alternatively or in addition, the shape and stiffness of the stylet 124 may be actively
controlled with the use of control wires or other similar devices. For instance, in
some embodiments, the stylet 124 has a tubular shape and features are cut partially
through the tube diameter near the distal end of the stylet 124. This allows the tube
to elastically bend in the region of the cut features. A thin wire is attached to
an inner wall of the tubular stylet 124 distally of the cut features and extends through
the proximal end of the tube to an actuating handle. When the wire is put under tension,
the distal end of the stylet 124 bends from its original shape. When the tension is
removed, the distal end of the stylet 124 recovers to its original shape. More than
one wire can be used for multiple bends. Such a stylet 124 may be comprised of any
suitable materials, particularly superelastic nitinol.
[0106] It may be appreciated that in some embodiments, the stylet 124 is fixedly attached
or embedded in the lead 100. In such instances, the stylet 124 serves to maintain
curvature, steerability and stiffness to the lead 100 and is not removed.
[0107] It may further be appreciated that the lead 100, stylet 124 or sheath 122 may alternatively
be manipulated by active steering control elements. Such control elements would be
managed by external controls.
[0108] It may further be appreciated that the stylet 124 and/or sheath 122 may have a substantially
straight configuration. Such a straight configuration may be particularly useful when
making larger bends, such as 90 degree bends. For example, if the nerve root angulation
of the target DRG is relatively large, a straight sheath 122 may be used to position
the lead 100 near the nerve root wherein the curved stylet 124 allows the lead 100
to bend along the nerve root angulation upon exiting the sheath 122. Thus, together
the sheath 122 and stylet 124 form an approximately 90 degree bend. Or, the curvature
of the sheath 122 itself may be sufficient to direct the lead 100 toward the target
DRG. In such instances, a straight stylet 124 may be used or the lead 100 may be advanced
without the use of a stylet.
Shapeable Sheath Embodiments
[0109] In some embodiments, the sheath 122 is comprised of a shapeable material. Such a
material is shapeable by simply bending the material, wherein the material substantially
maintains the bent shape. In preferred embodiments, the shapeable material comprises
polyimide with stainless steel wires embedded therein. The wires assist in providing
strength and shapeability. In some embodiments, the wires are embedded axially therein.
Any number of wires may be present, such as one, two, three, four, six, eight or more.
In some embodiments, four wires are present. The wires may have a variety of thicknesses.
Example materials include 470-VII.5 PTFE ID/BRAID w/4 AXIAL supplied by MicroLumen
(Tampa, FL). In other embodiments, one or more wires are embedded in a coiled configuration.
[0110] Typically, sheaths 122 comprised of a shapeable material have the same features as
the sheaths 122 described above and are used with the other delivery devices in the
same manner. However, the shapeable sheath does not rely on a preformed or preset
bend near its distal end. Rather, the shapeable sheath can be bent to any angle α
at the time of use. Likewise, the shapeable sheath can be rebent and readjusted as
many times as desired. This allows the practitioner to adjust the angle α as needed
before or during a procedure to more desirably access the target anatomy. This may
be particularly useful in patients that have irregular anatomy or unanticipated anatomical
features, such as due to progressive disease.
Multiple Sheath Embodiments
[0111] It may also be appreciated that multiple sheaths may be used to desirably direct
the lead 100 toward a target anatomy, such as a target DRG. For example, as illustrated
in Fig. 27, an additional sheath 122' may be used with the above described delivery
system 120. In such situations, the additional sheath 122' is advanceable through
sheath 122, and the lead 100 is advanceable through the additional sheath 122'. The
additional sheath 122' may have any desired curvature or may be substantially straight.
Each of the sheath 122, the additional sheath 122' and the lead 100 may be advanced
and retracted in relation to each other. In some embodiments, the sheaths are moveable
so that its distal end of the additional sheath 122' extends approximately 12-20mm,
typically approximately 15mm, beyond the distal end of the sheath 122. Such movements,
in combination with the shapes (e.g. curvatures) of the delivery devices, provide
increased maneuverability and variety in the angles through which the devices may
be advanced. In addition, the multiple sheath design increases the ability to impart
lateral forces, such as toward a foramen, particularly at substantial distances from
the entry point to the epidural space. As described above, the delivery system 120
may be used to target anatomy at multiple spinal levels above or below the insertion
point of the needle. The greater the distance from the insertion point, the ability
to impart lateral forces with the sheath 122 becomes more challenging. In some instances,
a foramen may be at least partially stenosed, creating difficulty in advancing a lead
therein. It may be desired to impart lateral forces with the sheath122 to access this
type of foramen. The additional sheath 122' provides additional stiffness, steerability,
and length which can be helpful in such access.
[0112] In some embodiments, the additional sheath 122' has a substantially straight configuration.
A straight configuration may be used to traverse greater expanses than with the sheath
122 alone. For example, in some patients and/or in some portions of the anatomy (such
as in the sacrum or when advancing through the sacral hiatus) the epidural space may
be particularly wide. Or, the sheath 122 may be positioned within the epidural space
between the midline and the "gutter" of the epidural space opposite the target DRG,
as illustrated in Fig. 28, so that a larger portion of the epidural space is to be
traversed. Traversing these greater expanses may be more easily achieved with the
use of an additional sheath 122'. In such embodiments, the additional sheath 122'
has a stiffness that allows for transverse translation. Advancement or translation
of the sheath 122' may be achieved with the use of, for example, a sliding mechanism
disposed within the hub 162. The lead 100 is then advanceable through the additional
sheath 122', such as described above, to a position so as to stimulate the target
DRG.
[0113] In one embodiment, the sheath 122 has an outer diameter of approximately 0.063 inches,
an inner diameter of approximately 1.45 mm (0.057 inches), and a working length of
approximately 30 cm. In this embodiment, the additional sheath 122' has an outer diameter
of approximately 1.32 mm (0.052 inches), an inner diameter of approximately 1.17 mm
(0.046 inches) and a working length of approximately 45cm. Together, the sheaths 122,
122' are passable through a 14 gauge needle having an inner diameter of approximately
1.7 mm (0.067 inches).
[0114] In some embodiments, the sheath 122 has a curvature and the additional sheath 122'
also has a curvature. In such instances, retraction of the additional sheath 122'
within the sheath 122 may cause the two curvatures to wedge together. This may be
prevented by restricting the distance the additional sheath 122 may be retracted within
the sheath 122. In some embodiments, this is achieved by a control hub 162 having
a sliding mechanism and a limiter. Figs. 29A, 29B, 29C illustrate a perspective view,
a side view and a front view, respectively, of an embodiment of such a control hub
162. Here, the hub 162 includes a base 300 and a slidable extender 302. The base 300
attaches to the proximal end of the sheath 122 and the slidable extender 302 attaches
to the proximal end of the additional sheath 122'. Advancement and retraction of the
extender 302 in relation to the base 300, moves the additional sheath 122' in relation
to the sheath 122. Such advancement and retraction is limited by a limiter. In this
embodiment, the limiter comprises a protrusion 306 along the extender 302 which protrudes
into a slot 308 along the base 300. The protrusion 306 slides along the slot 308 as
the extender 302 moves, limited at each end by the confines of the slot 308. Thus,
in this embodiment, advancement is limited in addition to retraction. Such limitation
of advancement may be used when a predetermined or known distance of advancement is
desired. In some embodiments, the predetermined distance is 15mm. Likewise, when repeated
advancement and retraction is desired, such as to penetrated through an obstruction,
the use of the limiter 304 may be desired. This allows quick, repeatable movements
through a known distance without risk of over-advancement or over-retraction. In some
embodiments, the hub 162 includes ergonomic handles to assist in manipulation. For
example, in one embodiment, the extender 302 includes a ring 310 and the base 300
includes hooks 312. Insertion of fingers under the hooks 312 and a thumb through the
ring 310 allows easy one-handed manipulation of the hub 162 by moving the thumb toward
and away from the fingers of the hand.
Other Embodiments
[0115] In some instances, the lead 100 has a preset curvature which assists in directing
the lead 100 to the target anatomy upon advancement.
[0116] The lead 100 and the stylet 124 may both have a curvature.
[0117] Any number of sheaths may be used with any combination of curvatures. Likewise, each
combination can be used with curved stylets or curved or straight leads.
[0118] The desired combination of devices and curvatures may depend on a variety of factors,
including the approach used (such as antegrade, retrograde or contralateral), the
choice of target anatomy, and the particular anatomical features of the individual
patient, to name a few.
[0119] It may further be appreciated that when a delivery device is described as directing
the lead toward a target anatomy, such direction may be in the general vicinity of
the target anatomy allowing for additional steps to direct the lead even closer toward
the target anatomy. For example, a curved sheath may direct the lead away from the
midline of the spinal column, toward a target DRG. However, straight advancement of
the lead therefrom may be below, above or not desirably close enough to the target
DRG. Therefore, additional directing of the lead toward the target DRG may be desired
to position the lead closer to the target DRG. The curved stylet may be used to direct
the lead again toward the target DRG, such as along a nerve root sleeve angulation.
Such steps may optimize positioning of the lead.
Connection to Implantable Pulse Generator
[0120] As mentioned above, the proximal ends of the leads 100 are connected with an IPG
which is typically implanted nearby, such as along the back, buttock or abdomen. The
IPG may be any conventional IPG which provides stimulation signals to the one or more
leads. Or, the IPG may be particularly adapted for targeted treatment of the desired
anatomies. For example, the delivery devices of the present invention may be used
in combination with the implantable stimulation system described in
U.S. Patent Publication No. 2010-0137938, "Selective Stimulation Systems and Signal Parameters for Medical Conditions" filed
October 27, 2009. Such targeted treatment minimizes deleterious side effects, such
as undesired motor responses or undesired stimulation of unaffected body regions.
This is achieved by directly neuromodulating a target anatomy associated with the
condition while minimizing or excluding undesired neuromodulation of other anatomies.
In some embodiments, the lead and electrode(s) are sized and configured so that the
electrode(s) are able to minimize or exclude undesired stimulation of other anatomies.
In other embodiments, the stimulation signal or other aspects are configured so as
to minimize or exclude undesired stimulation of other anatomies.
Strain Relief Support for Lead Connection to IPG
[0121] Typically, the IPG is surgically implanted under the skin at a location that is remote
from the stimulation site. The leads are tunneled through the body and connected with
the IPG to provide the stimulation pulses. Fig. 30 illustrates a conventional stimulation
system 510 used to stimulate tissues or organs within the body. The system 510 includes
an IPG 512 and at least one lead 514. The IPG 512 includes a header 516 having at
least one connection port 518 for electrically connecting with the lead 514. The lead
514 includes at least one electrode 520, typically disposed near its distal end 522,
and a conductive wire extending from each electrode 520 to its proximal end 524. The
proximal end 524 of the lead 514 is inserted into the connection port 518 to electrically
connect the conductive wire with the electronic circuitry within the IPG 512.
[0122] The leads are generally of a fragile nature and care must be taken to minimize strain
on the leads during implantation and throughout the life of the device. To reduce
strain on the lead, the lead is often implanted in a looped configuration and sutured
in place. In this manner, strain put on the lead may be absorbed by the looped coil.
However, this practice involves additional manipulation of the fragile lead and a
larger implantation area to accommodate the looped configuration.
[0123] In addition, a particularly vulnerable portion of the lead is the point of connection
with the IPG. It is typically desired that the lead be soft and "floppy" so as to
conform to bends in the anatomy along its path. In contrast, the IPG is typically
a rigid body configured to withstand encapsulation and tissue contraction. To connect
the lead to the IPG a portion of the lead is inserted into the IPG and fixed in place.
Thus, as the lead exits the IPG the lead endures an abrupt transition from fully supported
by the IPG to fully unsupported. This portion of the lead is vulnerable to kinking,
strain and damage. In addition, the soft and floppy characteristics of the lead may
also prove challenging when trying to insert the lead into the IPG.
[0124] Thus, it is desired to provide devices, systems and methods for improving handling
of the lead, including insertion of the lead into an IPG, and reducing any vulnerability
of the lead in the area of connection to the IPG. At least some of these objectives
will be met by the present invention.
[0125] Devices, systems and methods are provided to improve connectability of a lead, such
as a conventional lead or any of the leads of the present invention described herein,
to an IPG and to reduce any vulnerabilities of this connection. As mentioned above,
the soft and floppy characteristics of many leads may provide both handling issues
and longevity issues when connected with an IPG. For example, insertion of a floppy
lead into an IPG may be difficult and time consuming. And, the portion of the lead
exiting the IPG may be vulnerable to kinking, strain and damage. The present invention
assists in overcoming these issues by providing a strain relief support which is joinable
with the proximal end of a lead. The support provides rigidity to the proximal end
of the lead to assist in handling and insertion of the proximal end of the lead into
an IPG. And the support protects the lead from possible vulnerabilities near the connection
point with the IPG.
[0126] Fig. 31 illustrates an embodiment of a strain relief support 530. The support 530
comprises a support member 532 and a detachable hub 534. In this embodiment, the support
member 532 comprises an elongate shaft sized to be inserted into the proximal end
524 of a lead 514. Typically, the lead includes a plurality of lumens, such as a separate
lumen for each conductive wire. Additionally, the lead may include a stylet lumen
or other lumen. The support member 532 is typically inserted into the stylet lumen
or other lumen so as to internally support the proximal end of the lead. However,
it may be appreciated that the support member 532 may be inserted into any lumen or
be attached to an outer surface of the lead. The hub 534 is attachable to the support
member 532 to provide a handle or gripping structure to assist in manipulating the
support member 532.
[0127] The strain relief support 530 may be comprised of any suitable materials including
metals (such as stainless steel, nitinol, MP35N, etc.) or plastics (such as nylon,
polycarbonate, polyurethane, etc.).
[0128] Fig. 32 illustrates a cross-section of the strain relief support 530, including the
support member 532 and the hub 534. As shown, the support member 532 has an end structure
536 which is disposed within the hub 534. The hub 534 includes a plunger 538 comprising
a plunger button 540 attached to a plunger shaft 542. The plunger shaft 542 extends
through a channel 544 in the hub 534 toward the end structure 536 of the support member
532. Depression of the plunger button 540 translates the plunger shaft 542 through
the channel 544 so that the plunger shaft 542 contacts the end structure 536. Continued
depression applies force to the end structure 536 and pushes the end structure 536
out of the hub 534 as the hub material flexes to allow such movement. The support
member 532 is thus released and the hub 34 is considered detached. It may be appreciated
that the hub 534 may alternatively be detached by other mechanisms, such as by break-away
from a friction fit with the support member 532.
[0129] Figs. 33-35 illustrate insertion of the support member 32 into the proximal end 524
of a lead 514. Once the proximal end 524 of the lead 514 has been tunneled to a pocket
location within the patient's body and the pocket is ready to accept the IPG, the
proximal end 524 is ready to receive the support member 532. Typically, the support
member 532 is pre-attached to the hub 534 to allow easy grasping by the user. The
user holds the hub 534 and directs the support member 532 into the proximal end 524
of the lead 514, as shown in Fig. 33. In particular, the support member 532 is inserted
into a desired lumen in the lead 514. The hub 534 is then detached from the support
member 532 by depression of the plunger button 540, as illustrated in Fig. 34. Fig.
35 provides a side view of Fig. 34. As shown, the plunger shaft 542 has pushed the
end structure 536 out of the hub 534 so that the hub 534 is detached and can be disposed
or recycled. The support member 532 can be further inserted into the lead 514 so that
the end structure 536 abuts the lead 514, as shown in Fig. 36. Such insertion can
be achieved by pushing the end structure 536, such as with a finger or tool, until
the end structure 536 is desirably positioned. Typically, the end structure 536 is
sized to be larger than the lumen into which the support member 532 is being inserted
so as to remain outside of the lead 514. This resists distal migration of the support
member 532 and allows for easy removal of the support member 532 from the proximal
end 524 if desired. In this embodiment, the end structure 536 has a round or ball
shape, however it may be appreciated that the structure 536 may have any suitable
shape, particularly a shape which is easily graspable and resists insertion into the
lead 514. However, it may be appreciated that the end structure 536 may optionally
be sized and shaped to be inserted into the proximal end 524 of the lead 514 if desired.
[0130] The proximal end 524 of the lead 514 may then be inserted into the connection port
518 of the IPG 512, as illustrated in Fig. 37. The support member 532 provides rigidity
to the proximal end 524 of the lead 514 to assist in handling during insertion of
the proximal end 524 into the connection port 518. The proximal end 524 may then be
fixed within the connection port 518 with the use of a set screw 550. The set screw
550 is advanced toward the lead 514 and tightened against the lead 514 to hold the
lead 514 within the connection port 518 by frictional force. In some embodiments,
the lead 514 includes a cuff 552 aligned to contact the set screw 550. The cuff may
be comprised of any suitable material, such as MP35N (CoCr). Such fixation of the
support member 532 within the connection port 518 also resists dislodgement of the
support member 532 and possible migration.
[0131] As shown, the support member 532 extends beyond the IPG 512 so that the lead 514
is supported outside of the IPG 512. This diminishes the abrupt transition from fully
supported by the IPG 512 to fully unsupported. Consequently, this portion of the lead
is less vulnerable to kinking, strain and damage. It may be appreciated that the support
member 532 may be tapered toward its distal end to gradually reduce stiffness along
the lead 514 as the lead 514 exits the connection port 518.
[0132] The above described embodiment shows the support member 532 having a straight shape.
It may be appreciated that the support member 532 may alternatively have a curved,
bent, folded, compound shape or other shape.
Applications
[0133] It may be appreciated that the systems of the present invention may be used or adapted
for use in stimulating other neural targets or other tissues throughout the body.
Some examples include occipital nerves, peripheral nerve branches, nerves in the high
cervical area, nerves in the thoracic area, and nerves in the lower sacral area.
[0134] A variety of pain-related conditions are treatable with the systems of the present
invention. In particular, the following conditions may be treated:
- 1) Failed Back Surgery syndrome
- 2) Chronic Intractable Low Back Pain due to:
- A) Unknown Etiology
- B) Lumbar facet disease as evidenced by diagnostic block(s)
- C) Sacroiliac Joint disease as evidenced by diagnostic block(s)
- D) Spinal Stenosis
- E) Nerve root impingement - non-surgical candidates
- F) Discogenic Pain - discography based or not
- 3) Complex Regional Pain Syndrome
- 4) Post-Herpetic Neuralgia
- 5) Diabetic Neuropathic Pain
- 6) Intractable Painful Peripheral Vascular Disease
- 7) Raynaud's Phenomenon
- 8) Phantom Limb Pain
- 9) Generalized Deafferentation Pain Conditions
- 10) Chronic, Intractable Angina
- 11) Cervicogenic Headache
- 12) Various Visceral Pains (pancreatitis, etc.)
- 13) Post-Mastectomy Pain
- 14) Vulvodynia
- 15) Orchodynia
- 16) Painful Autoimmune Disorders
- 17) Post-Stroke Pain with limited painful distribution
- 18) Repeated, localized sickle cell crisis
- 19) Lumbar Radiculopathy
- 20) Thoracic Radiculopathy
- 21) Cervical Radiculopathy
- 22) Cervical axial neck pain, "whiplash"
- 23) Multiple Sclerosis with limited pain distribution
[0135] Each of the above listed conditions is typically associated with one or more DRGs
wherein stimulation of the associated DRGs provides treatment or management of the
condition.
[0136] Likewise, the following non-painful indications or conditions are also treatable
with the systems of the present invention:
- 1) Parkinson's Disease
- 2) Multiple Sclerosis
- 3) Demylenating Movement Disorders
- 4) Physical and Occupational Therapy Assisted Neurostimulation
- 5) Spinal Cord Injury - Neuroregeneration Assisted Therapy
- 6) Asthma
- 7) Chronic Heart Failure
- 8) Obesity
- 9) Stroke - such as Acute Ischemia
Again, each of the above listed conditions is typically associated with one or more
DRGs wherein stimulation of the associated DRGs provides treatment or therapy. In
some instances, Neuroregeneration Assisted Therapy for spinal cord injury also involves
stimulation of the spinal column.
[0137] It may be appreciated that the systems of the present invention may alternatively
or additionally be used to stimulate ganglia or nerve tissue. In such instances, the
condition to be treated is associated with the ganglia or nerve tissue so that such
stimulation provides effective therapy. The following is a list of conditions or indications
with its associated ganglia or nerve tissue:
- 1) Trigeminal Neuralgia (Trigeminal Ganglion)
- 2) Hypertension (Carotid Sinus Nerve / Glossopharangyl Nerve)
- 3) Facial Pain (Gasserian Ganglion)
- 4) Arm Pain (Stellate Ganglion)
- 5) Sympathetic Associated Functions (Sympathetic Chain Ganglion)
- 6) Headache (Pterygoplatine Ganglion/Sphenopalatine Ganglion)
[0138] It may also be appreciated that the systems and devices of the present invention
may also be used to stimulate various other nerve tissue including nerve tissue of
the peripheral nervous system, somatic nervous system, autonomic nervous system, sympathetic
nervous system, and parasympathetic nervous system, to name a few. Various features
of the present invention may be particularly suited for stimulation of portions of
these nervous systems. It may further be appreciated that the systems and devices
of the present invention may be used to stimulate other tissues, such as organs, skin,
muscle, etc.